ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • Biosimilars and rheumatoid arthritis (RA)
  • Biosimilars and rituximab
  • biosimilars and safety
  • Biostatistics
  • bipolar disorder and mood disorder questionnaire
  • Bisphosphonates
  • bisphosphonates and denosumab
  • bisphosphonates and infliximab
  • bisphosphonates and osteoarthritis
  • bisphosphonates and osteoporosis
  • Bisphosphonates and pregnancy
  • BK virus
  • Blau syndrome
  • bleomycin
  • blindness
  • blood brain barrier
  • blood pressure
  • BLyS
  • BLyS and Lupus
  • BLyS and systemic lupus erythematosus (SLE)
  • BMD
  • bmi
  • BMI and obesity
  • bmi and physical activity
  • bmp and chondrocytes
  • body composition
  • Body image
  • body image and quality of life
  • Body image and systemic sclerosis
  • body mass
  • Body mass and disability
  • body mass and etanercept
  • body mass and hip disorders
  • body mass and inflammation
  • Body mass and juvenile idiopathic arthritis (JIA)
  • body mass and obesity
  • Body mass and osteoporosis
  • body mass and Personalized Medicine
  • body mass and pharmacokinetics
  • body mass and prognostic factors
  • body mass and psoriatic arthritis
  • body mass and rheumatoid arthritis (RA)
  • body mass and tumor necrosis factor (TNF)
  • BOLD
  • Bone
  • Bone and gout
  • Bone and imaging techniques
  • Bone and inflammation
  • Bone and magnetic resonance imaging (MRI)
  • Bone and osteoblasts
  • Bone and prognostic factors
  • Bone and sarcoidosis
  • Bone and uric acid
  • bone attenuation coefficient and vertebral fracture
  • bone biology
  • bone biology and dendritic cells
  • bone biology and rheumatoid arthritis (RA)
  • bone biology and WNT Signaling
  • Bone density
  • bone density and bone quality
  • bone density and Cell Migration
  • bone density and dual energy x-ray absorptiometry (DEXA)
  • bone density and fracture risk
  • bone density and fractures
  • bone density and glucocorticoids
  • Bone density and metabolic syndrome
  • Bone density and osteoarthritis
  • bone density and osteoporosis
  • Bone density and physical activity
  • bone density and psoriatic arthritis
  • bone density and radiography
  • bone density and radiology
  • Bone density and rheumatoid arthritis (RA)
  • bone density and risk
  • bone density and sarcopenia
  • Bone density and spondylarthropathy
  • bone density and steroids
  • Bone density and systemic lupus erythematosus (SLE)
  • bone density and treatment
  • Bone density and uric acid
  • bone disease
  • bone disease and genetic disorders
  • bone disease and imaging techniques
  • bone disease and osteoclastogenesis
  • bone disease and osteoporosis
  • bone disease and rheumatoid arthritis (RA)
  • bone disease and treatment
  • bone disease and x-ray
  • Bone erosion
  • bone formation and adenosine receptors
  • bone health
  • Bone marrow
  • bone marrow and interferons
  • bone marrow and macrophage activation syndrome
  • bone marrow and osteoarthritis
  • Bone marrow and osteoclasts
  • bone marrow and rheumatoid arthritis (RA)
  • Bone marrow and scleroderma
  • bone marrow and systemic lupus erythematosus (SLE)
  • bone marrow lesions
  • bone marrow lesions and diagnostic imaging
  • bone marrow lesions and inflammation
  • bone marrow lesions and osteoarthritis
  • bone marrow lesions and rheumatoid arthritis (RA)
  • bone metabolism
  • bone metabolism and bone remodeling mediators
  • Bone metabolism and rheumatoid arthritis (RA)
  • Bone metabolism and spondylarthritis
  • Bone mineral density
  • bone mineral density and frailty
  • bone remodeling
  • bone remodeling and biopsies
  • bone remodeling and fractures
  • bone remodeling and prostaglandins
  • bone remodeling and rheumatoid arthritis (RA)
  • bone remodeling and spondylarthropathy
  • Bone Resorption
  • Bone turnover markers
  • bone turnover markers and bone density
  • bone turnover markers and inflammation
  • bone turnover markers and modified stoke ankylosing spondylitis spinal score (MSASSS)
  • Bone turnover markers and systemic lupus erythematosus (SLE)
  • Bortezomib
  • Bortezomib and SLE
  • botulinum toxin
  • botulinum toxin and pain management
  • botulinum toxin and treatment
  • Bowel
  • BR3
  • Brain
  • Brain Biopsy
  • Brain-derived neurotrophic factor
  • Brain-derived Neurotrophic Factor and Neuropsychological Assessment
  • BRD4 and systemic sclerosis
  • Breastfeeding
  • Brief Pain Inventory
  • Brodalumab
  • Bromodomain
  • bronchoalveolar lavage fluid and morbidity and mortality
  • BTK
  • BTK and rheumatoid arthritis (RA)
  • Burden of Adverse Drug Reactions
  • bursal puncture
  • business
  • business and rheumatoid arthritis (RA)
  • C protein-induced myositis
  • C Reactive Protein
  • C Reactive Protein and synovitis
  • C-reactive protein (CRP)
  • C-reactive protein (CRP) and Aging
  • C-reactive protein (CRP) and autoantibodies
  • C-reactive protein (CRP) and Disease Activity
  • C-reactive protein (CRP) and interleukins (IL)
  • C-reactive protein (CRP) and laboratory and imaging evaluation
  • C-reactive protein (CRP) and renal disease
  • C-reactive protein (CRP) and rheumatoid arthritis (RA)
  • C-reactive protein (CRP) and scleroderma
  • C1q
  • C1q and systemic lupus erythematosus (SLE)
  • C4 gene
  • C4B gene
  • C4BL gene
  • cachexia and myostatin
  • cadherin-11
  • Cadherins
  • calcinosis
  • calcinosis and dermatomyositis
  • Calcinosis and juvenile dermatomyositis
  • calcinosis and pyrophosphate
  • Calcinosis and scleroderma
  • Calcinosis and systemic sclerosis
  • Calcinosis and treatment
  • Calcitonin
  • Calcium
  • calcium and cardiovascular disease
  • Calcium and denosumab
  • Calcium and mesenchymal stem cells
  • calcium and rheumatoid arthritis (RA)
  • calcium and signal transduction
  • calcium and tendonitis/bursitis
  • Calcium and vasculitis
  • Calcium pyrophosphate dihydrate (CPPD)
  • Calcium pyrophosphate dihydrate (CPPD) and chondrocytes
  • Calcium pyrophosphate dihydrate (CPPD) and diagnosis
  • calcium pyrophosphate dihydrate (CPPD) and Electronic Health Record
  • Calcium pyrophosphate dihydrate (CPPD) and pseudogout
  • Calcium pyrophosphate dihydrate (CPPD) and rheumatoid arthritis (RA)
  • Calcium pyrophosphate dihydrate (CPPD) and synovial fluid
  • calcium pyrophosphate dihydrate (CPPD) and ultrasound
  • calcium signaling
  • Calgranulin
  • CALIPER and survival
  • calprotectin
  • calprotectin and atherosclerosis
  • calprotectin and longitudinal studies
  • CaMKIV and Treg
  • canakinumab
  • canakinumab and Biologics
  • Canakinumab and caregivers
  • canakinumab and corticosteroids
  • First |
  • « Previous Page
  • 5
  • 6
  • 7
  • 8
  • 9
  • [10]
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences